| First Author | Constantinou C | Year | 2016 |
| Journal | Am J Physiol Endocrinol Metab | Volume | 310 |
| Issue | 1 | Pages | E1-E14 |
| PubMed ID | 26530157 | Mgi Jnum | J:235911 |
| Mgi Id | MGI:5803936 | Doi | 10.1152/ajpendo.00429.2015 |
| Citation | Constantinou C, et al. (2016) Advances in high-density lipoprotein physiology: surprises, overturns, and promises. Am J Physiol Endocrinol Metab 310(1):E1-E14 |
| abstractText | Emerging evidence strongly supports that changes in the HDL metabolic pathway, which result in changes in HDL proteome and function, appear to have a causative impact on a number of metabolic disorders. Here, we provide a critical review of the most recent and novel findings correlating HDL properties and functionality with various pathophysiological processes and disease states, such as obesity, type 2 diabetes mellitus, nonalcoholic fatty liver disease, inflammation and sepsis, bone and obstructive pulmonary diseases, and brain disorders. |
